VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
COOThe Cooper Companies, Inc.
$65.91$12.9B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCOOP/E History

COO logoThe Cooper Companies, Inc. (COO) P/E Ratio History

Fairly Valued

Trading at 35.2x, near 5Y avg of 34.0x · 45th percentile · In line with own history · Data 1995–2026

Current P/E (TTM)
35.2x
+4% vs 5Y avg
5Y Avg P/E
34.0x
Median 39.7x
5Y Percentile
45th
Mid-range
PEG Ratio
N/A
5-Year P/E Range
35.2x
Min1.8xMedian39.7xMax70.4x
TTM EPS$1.21
Price$65.91
Earnings Yield2.84%
EPS Growth (1Y)-4.6%
EPS Growth (5Y)-17.2%

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, The Cooper Companies, Inc. (COO) trades at a price-to-earnings ratio of 35.2x, with a stock price of $65.91 and trailing twelve-month earnings per share of $1.21.

The current P/E is roughly in line with its 5-year average of 34.0x. Over the past five years, COO's P/E has ranged from a low of 1.8x to a high of 70.4x, placing the current valuation at the 45th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, COO trades at a 59% premium to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, COO commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our COO DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

COO Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
35.2vs22.1
+59%
Above Sector
vs. S&P 500
35.2vs24.4
+44%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -5% EPS growth (1Y)

COO P/E vs Peers

Dental and vision care devices peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
EW logoEWEdwards Lifesciences Corporation
$50B47.76.74-74%
HSIC logoHSICHenry Schein, Inc.
$9B24.47.75+7%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
JNJ logoJNJJohnson & Johnson
$550B39.4--58%
ABT logoABTAbbott Laboratories
$154B11.60.39Best+134%Best
BSX logoBSXBoston Scientific Corporation
$67B23.3-+55%
IDXX logoIDXXIDEXX Laboratories, Inc.
$45B43.03.01+23%
INMD logoINMDInMode Ltd.
$849M9.4Lowest0.94-36%
SYK logoSYKStryker Corporation
$118B36.62.46+8%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

COO Historical P/E Data (1995–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q2-$62.90$1.1853.3x+298%
FY2026 Q1Jan 31 2026$81.38$2.0240.3x+201%
FY2025 Q4Oct 31 2025$69.91$1.8837.2x+178%
FY2025 Q3-$70.69$2.0334.9x+160%
FY2025 Q2Apr 30 2025$81.67$2.0639.7x+197%
FY2025 Q1Jan 31 2025$96.55$2.0646.9x+250%
FY2024 Q4-$104.68$1.9553.7x+301%
FY2024 Q3Jul 31 2024$93.33$1.7952.1x+289%
FY2024 Q2-$89.06$1.7052.4x+291%
FY2024 Q1Jan 31 2024$93.26$1.4663.9x+377%
FY2023 Q4-$77.94$1.4852.7x+293%
FY2023 Q3Jul 31 2023$97.82$1.3970.4x+426%
FY2023 Q2Apr 30 2023$95.36$2.9432.4x+142%
FY2023 Q1-$87.23$5.2916.5x+23%
FY2022 Q4Oct 31 2022$68.35$6.7710.1x-25%
FY2022 Q3Jul 31 2022$81.75$8.659.5x-29%
FY2022 Q2Apr 30 2022$90.26$19.044.7x-65%
FY2022 Q1Jan 31 2022$99.57$18.855.3x-61%
FY2021 Q4Oct 31 2021$104.23$59.251.8x-87%
FY2021 Q3Jul 31 2021$105.44$58.681.8x-87%
FY2021 Q2Apr 30 2021$102.72$47.432.2x-84%
FY2021 Q1Jan 31 2021$91.01$45.302.0x-85%
FY2020 Q4Oct 31 2020$79.76$4.8116.6x+24%
FY2020 Q3Jul 31 2020$70.73$5.5912.7x-5%
FY2020 Q2-$71.68$6.8710.4x-22%
FY2020 Q1Jan 31 2020$86.72$9.099.5x-29%
FY2019 Q4-$72.75$9.347.8x-42%
FY2019 Q3Jul 31 2019$84.35$8.949.4x-30%
FY2019 Q2-$72.48$8.578.5x-37%
FY2019 Q1-$69.69$7.359.5x-29%
FY2018 Q4Oct 31 2018$64.58$2.7723.3x+74%
FY2018 Q3-$65.13$2.5325.7x+92%
FY2018 Q2Apr 30 2018$57.18$2.5922.1x+65%
FY2018 Q1Jan 31 2018$61.17$3.4817.6x+31%
FY2017 Q4-$60.06$7.528.0x-40%
FY2017 Q3Jul 31 2017$60.97$6.978.7x-35%
FY2017 Q2Apr 30 2017$50.08$6.677.5x-44%
FY2017 Q1-$46.15$6.077.6x-43%
FY2016 Q4Oct 31 2016$44.01$5.597.9x-41%
FY2016 Q3Jul 31 2016$45.62$5.118.9x-33%
FY2016 Q2Apr 30 2016$38.27$4.239.0x-32%
FY2016 Q1Jan 31 2016$32.79$3.948.3x-38%
FY2015 Q4Oct 31 2015$38.09$4.149.2x-31%
FY2015 Q3Jul 31 2015$44.25$4.0211.0x-18%
FY2015 Q2-$44.52$4.919.1x-32%
FY2015 Q1Jan 31 2015$39.41$5.307.4x-44%
FY2014 Q4Oct 31 2014$40.97$5.527.4x-45%
FY2014 Q3-$40.22$6.046.7x-50%
FY2014 Q2Apr 30 2014$32.98$6.035.5x-59%
FY2014 Q1Jan 31 2014$31.07$5.935.2x-61%
FY2013 Q4-$32.30$5.965.4x-60%
FY2013 Q3Jul 31 2013$31.84$6.275.1x-62%
FY2013 Q2-$27.60$5.844.7x-65%
FY2013 Q1-$25.34$5.444.7x-65%
FY2012 Q4Oct 31 2012$24.00$5.064.7x-65%
FY2012 Q3-$18.82$4.803.9x-71%
FY2012 Q2Apr 30 2012$22.04$4.345.1x-62%
FY2012 Q1-$18.04$3.954.6x-66%
FY2011 Q4Oct 31 2011$17.33$3.664.7x-65%
FY2011 Q3Jul 31 2011$19.12$3.505.5x-59%
FY2011 Q2Apr 30 2011$18.73$3.465.4x-60%
FY2011 Q1Jan 31 2011$14.34$2.835.1x-62%
FY2010 Q4Oct 31 2010$12.34$2.445.1x-62%
FY2010 Q3Jul 31 2010$9.72$2.064.7x-65%
FY2010 Q2Apr 30 2010$9.72$1.685.8x-57%
FY2010 Q1Jan 31 2010$8.83$2.124.2x-69%
FY2009 Q4Oct 31 2009$7.00$2.213.2x-76%
FY2009 Q3Jul 31 2009$6.86$2.203.1x-77%
FY2009 Q2-$7.19$2.113.4x-75%
FY2009 Q1Jan 31 2009$4.74$1.822.6x-81%
FY2008 Q4Oct 31 2008$4.12$1.442.9x-79%
FY2008 Q3-$8.43$0.2533.7x+152%
FY2008 Q2Apr 30 2008$8.75$0.04218.8x+1534%
FY2007 Q3-$12.53$0.6020.9x+56%
FY2007 Q2Apr 30 2007$12.78$0.8714.7x+10%
FY2007 Q1Jan 31 2007$11.93$1.1810.1x-24%
FY2006 Q4-$14.41$1.459.9x-26%
FY2006 Q3Jul 31 2006$11.05$1.288.6x-36%
FY2006 Q2Apr 30 2006$13.71$1.638.4x-37%
FY2006 Q1-$13.86$1.927.2x-46%
FY2005 Q4Oct 31 2005$17.21$1.998.6x-35%
FY2005 Q3Jul 31 2005$17.17$2.676.4x-52%
FY2005 Q2Apr 30 2005$16.89$2.576.6x-51%
FY2005 Q1Jan 31 2005$19.17$2.597.4x-45%
FY2004 Q4Oct 31 2004$17.59$2.686.6x-51%
FY2004 Q3Jul 31 2004$14.86$2.515.9x-56%
FY2004 Q2Apr 30 2004$13.50$2.395.6x-58%
FY2004 Q1Jan 31 2004$12.10$2.265.4x-60%
FY2003 Q4Oct 31 2003$10.86$2.155.1x-62%
FY2003 Q3-$8.76$2.024.3x-68%
FY2003 Q2Apr 30 2003$6.98$1.873.7x-72%
FY2003 Q1Jan 31 2003$6.40$1.713.7x-72%
FY2002 Q4-$6.63$1.584.2x-69%
FY2002 Q3Jul 31 2002$5.49$1.453.8x-72%
FY2002 Q2-$6.63$1.364.9x-64%
FY2002 Q1-$5.86$1.334.4x-67%
FY2001 Q4Oct 31 2001$6.00$1.244.8x-64%
FY2001 Q3-$6.04$1.175.2x-61%
FY2001 Q2Apr 30 2001$5.55$1.134.9x-63%
FY2001 Q1Jan 31 2001$4.83$1.084.5x-67%
FY2000 Q4-$4.47$1.014.4x-67%
FY2000 Q3Jul 31 2000$4.39$0.964.6x-66%
FY2000 Q2Apr 30 2000$4.20$0.785.4x-60%
FY2000 Q1Jan 31 2000$3.78$0.675.6x-58%
FY1999 Q4Oct 31 1999$3.13$0.595.3x-60%
FY1999 Q3Jul 31 1999$2.55$1.511.7x-87%
FY1999 Q2Apr 30 1999$1.97$1.721.1x-91%
FY1999 Q1Jan 31 1999$1.88$1.871.0x-92%
FY1998 Q4Oct 31 1998$2.97$2.001.5x-89%
FY1998 Q3Jul 31 1998$3.98$1.872.1x-84%
FY1998 Q2-$4.80$1.822.6x-80%
FY1998 Q1Jan 31 1998$6.20$1.763.5x-74%
FY1997 Q4Oct 31 1997$4.47$1.702.6x-80%
FY1997 Q3-$3.50$1.003.5x-74%
FY1997 Q2Apr 30 1997$2.23$0.922.4x-82%
FY1997 Q1Jan 31 1997$2.31$0.822.8x-79%
FY1996 Q4-$1.80$0.712.5x-81%
FY1996 Q3Jul 31 1996$1.36$0.206.8x-49%
FY1996 Q2-$1.38$0.149.9x-26%
FY1996 Q1Jan 31 1996$0.86$0.0713.2x-1%
FY1995 Q4-$0.73$0.0515.3x+14%
FY1995 Q3Jul 31 1995$1.03$0.254.1x-69%
FY1995 Q2Apr 30 1995$0.89$0.253.6x-73%
FY1995 Q1-$0.94$0.0237.8x+182%

Average P/E for displayed period: 13.4x

Export Data
Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into COO consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

31+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

COO — Frequently Asked Questions

Quick answers to the most common questions about buying COO stock.

What is COO's P/E ratio?

The Cooper Companies, Inc. (COO) trailing twelve-month P/E ratio is 35.2x, based on TTM diluted EPS of $1.21. The 5-year average P/E is 34.0x and the historical range spans 1.8x to 70.4x.

Is COO stock overvalued or undervalued?

COO trades at 35.2x P/E, near its 5-year average of 34.0x. The 45th percentile ranking within the 1.8x–70.4x historical range places valuation within normal bounds.

Is COO stock expensive?

COO is fairly valued relative to its own history. The current P/E of 35.2x is near the 5-year average of 34.0x (45th percentile of historical range).

What is COO's historical P/E range?

Over the past 5 years, COO's P/E ratio has ranged from 1.8x to 70.4x, with a median of 39.7x and an average of 34.0x. The current P/E of 35.2x places the stock at the 45th percentile of this range. Full historical data spans 1995–2026.

How does COO's P/E compare to the S&P 500?

COO trades at 35.2x P/E versus the S&P 500 median of 24.4x. The 44% premium to the market typically reflects higher expected earnings growth or quality.

How does COO's valuation compare to Healthcare peers?

The Cooper Companies, Inc. P/E of 35.2x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is COO's PEG ratio?

COO PEG ratio is N/A, based on a P/E of 35.2x and EPS growth of -4.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is COO's earnings yield?

COO earnings yield is 2.84%, the inverse of its 35.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

COO P/E Ratio History (1995–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current53.3x
Period Avg34.0x
Range1.8x - 70.4x
Change+2867%
20 quartersJul 31, 2021 - Apr 30, 2026